Tiera's Dermal Fillers: PLLA & HA Solutions for Clinics

Dermal fillers represent a cornerstone of non surgical aesthetic medicine, primarily designed to restore facial volume, diminish the appearance of wrinkles, and enhance structural contours. DERMECA hyaluronic acid dermal fillers, produced by Jiangsu TIERA Biotechnology, are sophisticated medical devices engineered through a proprietary cross linking technology that stabilizes the naturally occurring hyaluronic acid molecule. This process is critical for enhancing the product's longevity and resistance to enzymatic degradation, ensuring aesthetic results that can persist from six to eighteen months. The clinical applications for these fillers are extensive and tailored to specific patient needs. Common indications include mid face volumization for age related cheek deflation, precise lip augmentation for border definition and volume, correction of nasolabial folds and marionette lines, and non surgical chin augmentation to improve facial symmetry. In a documented clinical scenario following CFDA standard testing, patients receiving DERMECA fillers for moderate to severe nasolabial folds demonstrated a significant improvement on the Wrinkle Severity Rating Scale, with a high percentage of subjects maintaining satisfactory correction at the 12 month follow up. The manufacturing integrity is guaranteed by ISO13485 and MDSAP certifications, which enforce a rigorous quality management system spanning from raw material qualification to sterile filling and packaging. Each batch undergoes extensive analytical testing, including rheological profiling to ensure optimal G prime (elasticity) and cohesivity for predictable tissue integration and minimal risk of migration. For global partners, TIERA offers comprehensive OEM services, allowing for the customization of product characteristics such as particle size, viscosity, and syringe packaging to meet specific market demands and branding requirements. The company's dedication to safety is further evidenced by a robust portfolio of clinical data, which supports the product's favorable safety profile with a low incidence of transient and mild adverse events like erythema or edema. Aesthetic practitioners can leverage these fillers in advanced techniques, such as combining different product consistencies for a multi layer facial rejuvenation approach or using cannulas for safer injection in vascular rich areas. For detailed technical dossiers, specific clinical case studies, or to discuss customized OEM project possibilities, please contact our customer service team to initiate a confidential consultation.